Durowicz Sergiusz, Olszewski Waldemar L
Department of Surgical Research and Transplantology, Medical Research Center, Polish Academy of Sciences, 5 Pawinskiego, Warsaw 02-106, Poland.
J Immunol Methods. 2003 Jan 15;272(1-2):117-24. doi: 10.1016/s0022-1759(02)00438-6.
Portal blood leukocytes play an important, but still poorly defined, role in the immune processes of the liver. In our previous studies, we showed that certain leukocyte subsets are selectively halted in the liver. These cells marginate in sinusoids and, together with resident Kupffer and endothelial sinusoidal cells, participate in antiviral and antitumor processes. The molecular mechanisms of margination and cooperation with resident sinusoidal cells require clarification. However, in vivo harvesting of portal blood leukocytes is associated with cumbersome cannulation of portal and hepatic veins and manipulation of the liver, causing major disturbances in splanchnic blood flow and liver blood supply, totally distorting sinusoidal blood perfusion and leukocyte margination. To overcome these difficulties, we have developed an in situ normothermic rat liver perfusion model permitting quantitative observations of blood leukocyte extraction in sinusoids. First, liver was flushed through the portal vein and the effluent leukocytes, named liver-associated leukocytes (LAL1), were collected from hepatic veins. Then, the liver was perfused for 60 min with 50 ml of blood using a semiclosed perfusion system. Upon completion of perfusion, the liver portal vasculature was flushed again to retrieve the leukocytes extracted from the perfusing blood (LAL2). These cells were characterized with respect to their phenotype and cytotoxicity. The mean leukocyte count of the washout before perfusion was 1.04+/-0.2x10(6)/g of liver tissue and 0.9+/-0.1x10(6)/g after 60 min of perfusion, indicating retention by the perfused liver, the live leukocyte extracting capacity. To further evaluate the efficiency of perfusion, FITC-labelled leukocytes were added to the perfusing leukocyte-free blood. Around 95% of the postperfusion washout LALs were FITC(+). Heat-killed leukocytes did not marginate in sinusoids. Preincubation of leukocytes with substances able to lower adhesion capacity, such as lidocaine, trypsin and AAGM1, significantly decreased the postperfusion LAL2 washout population. The numbers of extracted postperfusion LAL2 CD5(+), CD4(+), CD8(+), CD56(+) and class II(+) subsets did not differ statistically from those of preperfusion LAL1. Moreover, the cytotoxicity of LAL2 and LAL1 against CC531 and K562 remained at a similar level. Thus, perfused liver also retained its selective leukocyte extraction capacity. This model shows that the process of selective margination of portal blood cell subsets in the liver can be studied in an artificially perfused liver subject to physiological blood flow parameters, temperature, oxygenation and minimal ischemic time before connection to the perfusion device. Furthermore, it is suitable for studies of the selective recruitment of blood cells in sinusoids in a wide large of situations including liver tumors, infections, rejection after transplantation, graft vs. host disease, as well as in the investigation of the effect of drugs on these processes.
门静脉血白细胞在肝脏免疫过程中发挥着重要作用,但目前其作用仍未完全明确。在我们之前的研究中,我们发现某些白细胞亚群在肝脏中会被选择性滞留。这些细胞在肝血窦中边缘化,并与驻留的库普弗细胞和内皮血窦细胞一起参与抗病毒和抗肿瘤过程。边缘化以及与驻留血窦细胞合作的分子机制尚待阐明。然而,在体内采集门静脉血白细胞与门静脉和肝静脉的繁琐插管以及肝脏操作相关,会导致内脏血流和肝脏血液供应出现重大紊乱,完全扭曲血窦血流灌注和白细胞边缘化。为克服这些困难,我们开发了一种原位常温大鼠肝脏灌注模型,可对肝血窦中血液白细胞提取进行定量观察。首先,通过门静脉冲洗肝脏,并从肝静脉收集流出的白细胞,称为肝脏相关白细胞(LAL1)。然后,使用半封闭灌注系统用50毫升血液对肝脏灌注60分钟。灌注完成后,再次冲洗肝脏门静脉系统以回收从灌注血液中提取的白细胞(LAL2)。对这些细胞的表型和细胞毒性进行了表征。灌注前冲洗液中的白细胞平均计数为1.04±0.2×10⁶/克肝脏组织,灌注60分钟后为0.9±0.1×10⁶/克,表明灌注后的肝脏具有滞留能力,即活白细胞提取能力。为进一步评估灌注效率,将异硫氰酸荧光素(FITC)标记的白细胞添加到无白细胞的灌注血液中。灌注后冲洗出的LAL中约95%为FITC阳性。热灭活的白细胞不会在血窦中边缘化。用能够降低黏附能力的物质(如利多卡因、胰蛋白酶和AAGM1)对白细胞进行预孵育,可显著减少灌注后LAL2冲洗出的细胞数量。灌注后提取的LAL2 CD5⁺、CD4⁺、CD8⁺、CD56⁺和II类⁺亚群的数量与灌注前LAL1的数量在统计学上无差异。此外,LAL2和LAL1对CC531和K562的细胞毒性保持在相似水平。因此,灌注后的肝脏也保留了其选择性白细胞提取能力。该模型表明,在连接到灌注装置之前,在符合生理血流参数、温度、氧合且缺血时间最短的人工灌注肝脏中,可以研究肝脏中门静脉血细胞亚群的选择性边缘化过程。此外,它适用于研究多种情况下肝血窦中血细胞的选择性募集,包括肝肿瘤、感染、移植后排斥反应、移植物抗宿主病,以及研究药物对这些过程的影响。